Recent News

• 05.12.2025 - ProMIS Neurosciences Announces First Quarter 2025 Financial Results
• 05.12.2025 - ProMIS Neurosciences Announces First Quarter 2025 Financial Results
• 03.31.2025 - ProMIS Neurosciences Announces Full Year 2024 Financial Results and Recent Highlights
• 03.31.2025 - ProMIS Neurosciences Announces Full Year 2024 Financial Results and Recent Highlights
• 03.24.2025 - ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference
• 03.24.2025 - ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference
• 03.13.2025 - ProMIS Neurosciences Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases at the American Academy of Neurology 2025 Annual Meeting
• 03.13.2025 - ProMIS Neurosciences Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases at the American Academy of Neurology 2025 Annual Meeting
• 03.11.2025 - ProMIS Neurosciences to Participate in the 37th Annual Roth Conference
• 03.11.2025 - ProMIS Neurosciences to Participate in the 37th Annual Roth Conference

Recent Filings

• 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.29.2025 - DEF 14A Other definitive proxy statements
• 04.29.2025 - ARS Annual Report to Security Holders
• 03.31.2025 - 8-K Current report
• 03.31.2025 - EX-99.1 EX-99.1
• 03.31.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.25.2025 - 8-K Current report